Our team relies on its many years of experience and past successes, to prepare and execute numerous technology transfers for the manufacture of hyaluronic acid products (cross-linked or non-cross-linked HA), in Europe but also outside Europe, particularly in China and the Middle East. These operations have led us in particular to improve the pre-existing technologies at our customers, scale up and provide them with more modern technologies.
Company
Technology transfer
Explore our environment
-
They Trust SyrHA : The Excellence of a CDMO
At SyrHA, we believe that the cornerstone of our success is the unwavering trust that…
-
Announcing strategic partnership : SyrHA the CDMO and ISHAS organization
We are pleased to inform you that SyrHA has joined the International Society for Hyaluronic…
-
CDMO: Evolution of their role
Innovative biopharmaceutical companies are increasingly engaging in strategic partnerships with CDMOs, whereas in the past,…
-
Join us at IMCAS Paris!
We’re delighted to announce that our team will be taking part in the IMCAS 2024…
-
SyrHATech is thrilled to install its new autoclave!
In the field of sterile medical device manufacturing, the terminal sterilization of your products is…
-
SyrHATech goes to CPHI Barcelona – from 10/24 to 10/26
The CPHI (Convention on Pharmaceutical Ingredients) is the reference event for the pharmaceutical industry. Itinerant…
-
Inauguration of Syrhatech’s new premises in Geneva
The Syrhatech team was delighted to share a convivial moment on its terrace on the…
-
Development of a specific syringe for wrinkle filler
Our customer contacts us to validate the design of a syringe made of plastic by…
-
Development of an innovative gel with very high concentration
Our client contacts us to industrialize a new manufacturing technique, compatible with the objectives of…
-
Technology transfer
Our team relies on its many years of experience and past successes, to prepare and…
